Product Description
Anti-TNF (Ozoralizumab) -MC-Vc-PAB-DMEA- (PEG2) -duocarmycin SA ADC | ADC-W-1831 | Creative Biolabs
Short Description: This ADC product is comprised of an anti-TNF VHH conjugated via a MC-Vc-PAB-DMEA- (PEG2) linker to duocarmycin SA
Status: In stock
Expected Delivery Time: 9-11Weeks